MedPath

Genomic Predictors of Recurrent Pregnancy Loss

Recruiting
Conditions
Recurrent Pregnancy Loss
Registration Number
NCT05444283
Lead Sponsor
Yale University
Brief Summary

The overall goals of this proposal are to determine the genetic architecture of recurrent pregnancy loss (RPL) and to discover genomic predictors of RPL.

Detailed Description

The following specific aims are proposed:

Aim 1: Collect clinically well-characterized samples from trios (product of conception (POC), biological mother, and biological father) with unexplained RPL. Specifically, a cohort of 1,000 trios that are rigorously-phenotyped will be recruited, and for which couples' RPL is not attributable to known causes. The POC and parental DNA samples will be collected. If it is necessary for the purpose of determining the pathogenicity of sequence variants from the trio, collecting DNA samples from other family members after consent will also be considered. The study team may also request DNA or POC tissues from a prior pregnancy loss(es) if available.

Aim 2: A whole genome sequencing (WGS) at the Yale Center for Genome Analysis (YCGA) will be performed and bioinformatic analyses to identify pathogenic variants in included trios will performed as well. Pathogenic variants will be comprehensively defined and fully annotated variant maps in all included trios to provide the substrate for subsequent novel gene discovery, and ultimately, the development of clinical diagnostic tests will be generated.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine genetic etiology for Recurrent Pregnancy Loss5 years

The WGS tool will be used to analyze the POC sample and parental blood samples to determine the clinical reportable genetic cause for RPL

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (11)

University of Colorado

🇺🇸

Aurora, Colorado, United States

Yale University

🇺🇸

New Haven, Connecticut, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

University of Chicago

🇺🇸

Chicago, Illinois, United States

Gaelle Massoud

🇺🇸

Baltimore, Maryland, United States

Wayne State University

🇺🇸

Detroit, Michigan, United States

Columbia University

🇺🇸

New York, New York, United States

University of Oklahoma

🇺🇸

Oklahoma City, Oklahoma, United States

Pennsylvania State University

🇺🇸

Hershey, Pennsylvania, United States

University of Texas at Austin

🇺🇸

Austin, Texas, United States

Scroll for more (1 remaining)
University of Colorado
🇺🇸Aurora, Colorado, United States
Katherine Khun, MS
Contact
303-724-5276
KATHERINE.KUHN@CUANSCHUTZ.EDU
Nanette Santoro, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.